Analysis of Inflammatory Mediators in Type 2 Diabetes Patients

Table 1

Demographic information and laboratory investigations of the T2DM patients.

Characteristics	Mean ± SD/𝑛 (%)
	T2DM patients	Healthy controls
Age	52.3 ± 11.5	35 ± 7
Sex
Male	28 (49)	20 (67%)
Female	29 (51)	10 (33%)
Disease duration
≥5 years	51 (89.4)	NA
<5 years	6 (10.6)
Height	158.8 ± 7.8	165 ± 10
Weight	76.8 ± 13.8	73 ± 10.2
BMI	30.4 ± 5.2	NA
HbA1c	8.2 ± 1.4	NA
CRP	11.1 ± 24.6	NA
Vitamin D	44.2 ± 20.2	NA
Hypertension	38 (67)	0
TC	5.1 ± 1.1	NA
LDL	3.1 ± 1.0	NA
HDL	1.2 ± 0.4	NA
TG	1.6 ± 1.1	NA
Current smokers	2 (3.5)	0
Treatment (%)		NA
Insulin	12 (21)
Oral
(Metformin/sulfonylurea)	27 (47)
(Metformin only)	4 (7)
Oral + insulin	9 (16)
Diet + exercise	5 (9)

T2DM: type 2 diabetes mellitus; BMI: body mass index; HbA1c: glycated haemoglobin; CRP: C-reactive protein; TC: total cholesterol; LDL: low-density lipoprotein; HDL: high-density lipoprotein; TG: triglycerides. NA: not available.